School of Medicine

A new grant from the Centers for Disease Control and Prevention (CDC) will support research at the School of Medicine to investigate the real-world effectiveness of COVID-19 and influenza vaccines.

Adetunji T. Toriola, MD, PhD, a William H. Danforth Washington University Physician-Scientist Scholar, has received the 2022 Outstanding Investigator Award for Breast Cancer Research from the American Association for Cancer Research.

The School of Medicine and pharmaceutical company Eisai Co. Ltd. have formed a research collaboration aimed at developing new treatments for Alzheimer’s disease and other neurodegenerative conditions.

A large study conducted in part by School of Medicine researchers focused on whether exercise and mindfulness training could boost cognitive function in older adults. The study found no such improvement following the interventions.

Thorold Theunissen, at the School of Medicine, has been named to an editorial board of early-career scientists for the journal Stem Cell Reports.

Proscovia Nabunya, at the Brown School; and Patricia Cavazos-Rehg, at the School of Medicine, have received a five-year $1.2 million research grant from the National Institute of Mental Health, part of the National Institutes of Health (NIH), to address depression among youth living with HIV in Uganda.

A nasal COVID-19 vaccine based on technology licensed from Washington University in St. Louis has been approved for emergency use in India as a booster for people who have already received two doses of other COVID-19 vaccines.

The National Academy of Inventors has elected two Washington University faculty members to its 2022 cohort of fellows: Guy Genin, at the McKelvey School of Engineering, and Farshid Guilak, at the School of Medicine.

A study involving School of Medicine researchers supports the idea that some T cells that react to microbes also may react to normal human proteins, causing autoimmune disease. The findings promise to accelerate efforts to improve diagnostic tools and treatments for autoimmune diseases.

Researchers at the School of Medicine have discovered that vaccinating mice against a bacterial toxin produced by E. coli can prevent intestinal damage. The finding suggests new ways to prevent malnutrition and stunting in children.